These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17117045)

  • 1. Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Takei K; Ueno Y; Tomita Y; Yamamoto Y
    ASAIO J; 2006; 52(6):e37-9. PubMed ID: 17117045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.
    Ueno T; Ikeda T; Ikeda K; Taniuchi H; Suda S; Yeung MY; Matsuno N
    J Surg Res; 2011 Nov; 171(1):183-90. PubMed ID: 20338589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
    J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
    Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
    Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
    Uriu K; Osajima A; Kamochi M; Watanabe H; Aibara K; Kaizu K
    Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels.
    Nakamura T; Kawagoe Y; Ueda Y; Yamada S; Koide H
    Blood Purif; 2011; 32(2):139-42. PubMed ID: 21654166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of endotoxin scattering photometry for determining the efficacy of polymyxin B-immobilized fiber treatment in septic shock: report of a case.
    Sakamoto Y; Mashiko K; Obata T; Yokota H
    J Nippon Med Sch; 2010 Apr; 77(2):119-22. PubMed ID: 20453426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
    Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
    Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
    Nakamura T; Kawagoe Y; Ueda Y; Koide H
    ASAIO J; 2005; 51(4):482-4. PubMed ID: 16156319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
    Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
    Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.